George Gourzoulidis;Maria Koulentaki;Anna Koumarianou;Epaminondas Samadas;Nikolaos Androulakis;Spyridon Xynogalos;Pavlos Papakotoulas;Ioannis Boukovinas;Michalis Karamouzis;John Souglakos;Vasiliki Chotzagiannoglou;Alexandra Beletsi;Georgia Kourlaba;. (2021). Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece . Expert Review of Pharmacoeconomics & Outcomes Research, (), –.
doi:10.1080/14737167.2021.1921576
